Trial intelligence / Profile preview

RECOVER: Low vs Normal Pressure Pneumoperitoneum in Colorectal Surgery

NCT03608436Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Oct 2018
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of rocuronium in Colorectal disease (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Quality of Recovery-40 at 24 hours. Started Oct 2018; status: completed.

02

Drugs

rocuronium
03

Conditions

Colorectal disease

Beyond the preview

Go deeper on NCT03608436.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03608436.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call